Collectively, these data strongly support the hypothesis that ADAMTS9-AS2 impedes ccRCC cell proliferation and decreases chemoresistance via acting as a miR-27a-3p sponge. Here, ADAMTS9 is linked to nonpapillary renal cell carcinoma.